SCHEMBL20840356

SCHEMBL20840356

O=C(O)CCOCCOCCOCCOCCOCCO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
TSHR P16473 5/20 0.53
MAPK1 P28482 1/20 0.53
CAMK2A Q9UQM7 1/20 0.43
LMNA P02545 3/20 0.40
GPR84 Q9NQS5 1/20 0.40
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40
SUCNR1 Q9BXA5 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
PMP22 Q01453 2/20 0.39
BLM P54132 1/20 0.39
HSD17B10 Q99714 1/20 0.39
THRB P10828 1/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 2/20 0.38
SLC22A6 Q4U2R8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29282163 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL2555371 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL931815 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL4588453 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL19402669 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL16329219 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL22445115 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL22445005 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1CAMK2A
Hydrochloric Acid SCHEMBL28335348 0.97 MEN1 (0.55) MEN1KMT2ATSHRMAPK1CAMK2A
SCHEMBL46587 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11566057-B2 Long-acting co-agonists of the glucagon and GLP-1 receptors MERCK SHARP & DOHME LLC (US) 2023-01-31 US disclosed
US-11566057-B2 Long-acting co-agonists of the glucagon and GLP-1 receptors MERCK SHARP & DOHME LLC (US) 2023-01-31 US disclosed
EP-3700550-A1 LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS Merck Sharp & Dohme Corp. (US) 2020-09-02 EP disclosed
US-20200270325-A1 LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS MERCK SHARP & DOHME CORP. (US) 2020-08-27 US disclosed
US-20200270325-A1 LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS MERCK SHARP & DOHME CORP. (US) 2020-08-27 US disclosed
CN-111132690-A Long-acting co-agonists of glucagon and GLP-1 receptor 默沙东公司 2020-05-08 CN disclosed
WO-2019060660-A1 LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS MERCK SHARP & DOHME CORP. (US) 2019-03-28 WO disclosed
WO-2019060660-A1 LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS MERCK SHARP & DOHME CORP. (US) 2019-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566057-B2 Long-acting co-agonists of the glucagon and GLP-1 receptors GLP1R, GCGR, GIPR MEN1 897/4885KMT2A 3576/4885TSHR 43/4885
US-20200270325-A1 LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS GLP1R, GCGR, GIPR MEN1 897/4885KMT2A 3576/4885TSHR 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.